Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Guangdong Taienkang Pharmaceutical (301263)
- 28.53
- -0.24-0.83%
Market Closed Apr 24 15:00 CST
12.14BMarket Cap518.73P/E (TTM)
28.83High28.32Low31.92KlotVolume28.71Open28.77Prev Close91.13MTurnover1.05%Turnover Ratio112.32P/E (Static)425.50MShares42.2652wk High7.00P/B8.66BFloat Cap19.1052wk Low34.52Limit Up303.59MShs Float42.26Historical High23.02Limit Down1.77%Range %10.71Historical Low0.20Dividend TTM28.55Avg Price16.10KlotAsk0.70%Div Yield TTM100Lot Size14.13KlotBid
Guangdong Taienkang Pharmaceutical (301263) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -8.13%525.83M | -12.23%347.08M | -2.35%184.66M | -5.23%721.03M | -1.50%572.37M | -2.39%395.43M | -2.41%189.11M | -2.90%760.79M | 1.34%581.1M | 8.09%405.09M |
| Operating revenue | -8.13%525.83M | -12.23%347.08M | -2.35%184.66M | -5.23%721.03M | -1.50%572.37M | -2.39%395.43M | -2.41%189.11M | -2.90%760.79M | 1.34%581.1M | 8.09%405.09M |
| Other operating revenue | ---- | 21.81%589.37K | ---- | 20.49%862.97K | ---- | 35.08%483.86K | ---- | 4.59%716.24K | ---- | 11.81%358.19K |
| Total operating cost | 14.87%506.5M | 8.03%320.6M | 6.67%145.91M | 8.47%618.13M | 5.62%440.93M | 6.61%296.77M | 3.55%136.78M | -2.61%569.87M | -2.07%417.46M | -1.31%278.37M |
| Operating cost | 5.68%233.42M | 4.91%159.17M | 1.69%70.82M | 4.26%312.48M | 1.35%220.88M | 2.51%151.73M | 2.73%69.64M | -8.45%299.72M | -10.44%217.95M | -7.02%148.01M |
| Operating tax surcharges | -8.47%6.29M | -7.77%4.33M | -3.15%2.11M | -1.10%9.7M | -6.49%6.87M | -8.87%4.69M | -26.92%2.17M | 25.86%9.81M | 36.30%7.35M | 47.42%5.15M |
| Operating expense | 52.29%143.53M | 27.42%79.33M | 25.35%35.75M | -4.92%130.44M | -5.30%94.25M | -7.13%62.26M | -10.70%28.52M | -12.84%137.2M | -9.05%99.52M | -11.32%67.03M |
| Administration expense | 19.56%64.46M | 10.98%39.94M | 10.64%20.03M | 12.64%74.74M | 10.13%53.91M | 11.41%35.99M | 16.60%18.1M | 20.70%66.35M | 17.32%48.95M | 12.47%32.3M |
| Financial expense | 33.30%4.55M | 31.94%3.87M | 43.95%2.29M | 171.39%4.35M | 163.03%3.42M | 158.08%2.93M | 177.96%1.59M | -118.43%-6.09M | -566.00%-5.42M | -1,085.55%-5.05M |
| -Interest expense (Financial expense) | 13.79%6.75M | 20.57%4.56M | 30.35%2.04M | 407.31%8.63M | 680.94%5.93M | 832.93%3.79M | 621.67%1.56M | -33.94%1.7M | -67.28%759.78K | -77.31%405.73K |
| -Interest Income (Financial expense) | 30.75%-2.73M | 63.53%-865.9K | 38.08%-367.01K | 23.56%-6.71M | 46.47%-3.95M | 55.88%-2.37M | 71.39%-592.68K | 10.44%-8.78M | -17.92%-7.37M | -13.12%-5.38M |
| Research and development | -11.94%54.24M | -13.31%33.96M | -10.98%14.91M | 37.42%86.42M | 25.42%61.6M | 26.66%39.17M | 5.34%16.75M | 55.69%62.89M | 94.73%49.11M | 112.09%30.93M |
| Credit Impairment Loss | 23.32%-3.66M | 12.54%-2.55M | -63.76%-1.86M | 106.88%296.04K | -15.89%-4.77M | -2.39%-2.91M | -6.59%-1.13M | -36.19%-4.3M | 15.23%-4.12M | 25.36%-2.84M |
| Asset Impairment Loss | 126.33%402.63K | 103.46%47.31K | 15.85%-630.82K | 47.07%-5.49M | -2,747.28%-1.53M | -2,408.46%-1.37M | 54.14%-749.61K | -910.71%-10.36M | 106.50%57.76K | 106.35%59.22K |
| Other net revenue | -26.80%2.08M | -7.82%1.53M | -95.84%120.81K | 31,139.92%5.68M | -58.58%2.85M | -67.31%1.66M | 88.60%2.9M | -99.83%18.18K | 113.24%6.87M | 630.86%5.08M |
| Fair value change income | 163.72%340.5K | -69.10%92.76K | -72.34%431.27K | -87.48%100.6K | -93.18%129.11K | 839.53%300.23K | 40.11%1.56M | 23.87%803.45K | -47.16%1.89M | -103.22%-40.6K |
| Invest income | -83.39%434.53K | -69.59%587.38K | 304.20%157.4K | -63.64%2.8M | -49.75%2.62M | -63.99%1.93M | -97.62%38.94K | -17.39%7.7M | 164.39%5.21M | --5.36M |
| Asset deal income | --12.83K | --12.72K | ---- | ---- | ---- | ---- | ---- | 1,273.18%149.37K | 641.41%150.72K | 897.34%150.72K |
| Other revenue | -28.89%4.55M | -9.98%3.34M | -36.66%2.02M | 32.13%7.97M | 74.03%6.4M | 54.89%3.71M | 136.82%3.19M | 18.19%6.03M | 6.86%3.68M | -5.93%2.39M |
| Operating profit | -84.05%21.42M | -72.08%28.01M | -29.61%38.88M | -43.13%108.58M | -21.24%134.29M | -23.89%100.32M | -12.66%55.23M | -8.74%190.93M | 13.39%170.51M | 43.67%131.8M |
| Add:Non operating Income | 213.90%32.36K | 7,697.65%89.81K | 6,334.55%62.37K | -87.98%282.12K | -99.56%10.31K | -99.95%1.15K | -99.96%969.33 | 54.69%2.35M | 39.02%2.35M | 46.14%2.21M |
| Less:Non operating expense | -6.12%1.78M | -14.02%1.37M | -2.92%1.21M | 245.45%3.29M | 224.56%1.9M | 468.76%1.59M | 1,180.11%1.24M | -71.71%953.4K | -44.74%584.85K | -67.25%279.36K |
| Total profit | -85.15%19.67M | -72.92%26.74M | -30.11%37.73M | -45.11%105.57M | -23.14%132.4M | -26.17%98.73M | -17.38%53.99M | -7.25%192.32M | 14.08%172.27M | 44.74%133.74M |
| Less:Income tax cost | -108.41%-2.3M | -125.76%-5.18M | -39.11%7.04M | -78.02%8.53M | -21.79%27.38M | -24.50%20.09M | -15.42%11.56M | 18.55%38.82M | 46.81%35.01M | 79.25%26.61M |
| Net profit | -79.08%21.97M | -59.42%31.91M | -27.66%30.69M | -36.78%97.04M | -23.49%105.02M | -26.59%78.64M | -17.90%42.43M | -12.09%153.5M | 7.95%137.26M | 38.13%107.13M |
| Net profit from continuing operation | -79.08%21.97M | -59.42%31.91M | -27.66%30.69M | -36.78%97.04M | -23.49%105.02M | -26.59%78.64M | -17.90%42.43M | -12.09%153.5M | 7.95%137.26M | 38.13%107.13M |
| Less:Minority Profit | 16.64%-9.44M | 27.23%-5.17M | 71.98%-852.12K | -66.93%-11.18M | -148.00%-11.32M | -268.66%-7.11M | -877.34%-3.04M | -68,498.51%-6.7M | -93,614.68%-4.56M | -79,227.56%-1.93M |
| Net profit of parent company owners | -73.00%31.41M | -56.75%37.08M | -30.62%31.55M | -32.45%108.22M | -17.97%116.34M | -21.37%85.75M | -12.54%45.47M | -8.26%160.2M | 11.53%141.82M | 40.61%109.05M |
| Earning per share | ||||||||||
| Basic earning per share | -74.07%0.07 | -55.00%0.09 | -36.36%0.07 | -31.58%0.26 | -18.18%0.27 | -23.08%0.2 | -8.33%0.11 | -13.64%0.38 | 0.00%0.33 | 23.81%0.26 |
| Diluted earning per share | -74.07%0.07 | -55.00%0.09 | -36.36%0.07 | -31.58%0.26 | -18.18%0.27 | -23.08%0.2 | -8.33%0.11 | -13.64%0.38 | 0.00%0.33 | 23.81%0.26 |
| Other composite income | -47.22%-384.91K | -32,993.13%-612.56K | -440.65%-197.96K | 95.88%-25.27K | 24.71%-261.45K | 99.74%-1.85K | 152.13%58.11K | -401.98%-612.91K | -159.30%-347.24K | -270.88%-709.09K |
| Other composite income of parent company owners | -47.22%-379.94K | -32,993.06%-604.65K | -440.65%-195.4K | 95.85%-24.94K | 24.16%-258.08K | 99.74%-1.83K | 152.51%57.36K | -401.35%-600.64K | -159.30%-340.3K | -270.88%-694.9K |
| Other composite income of minority owners | -47.22%-4.97K | -32,998.66%-7.9K | -440.65%-2.55K | 97.34%-326.08 | 51.42%-3.37K | 99.83%-23.88 | 133.63%749.84 | -436.38%-12.27K | -159.30%-6.94K | -270.88%-14.18K |
| Total composite income | -79.40%21.58M | -60.20%31.3M | -28.22%30.5M | -36.55%97.01M | -23.49%104.75M | -26.10%78.64M | -17.61%42.49M | -12.54%152.89M | 7.18%136.91M | 36.48%106.42M |
| Total composite income of parent company owners | -73.27%31.03M | -57.46%36.48M | -31.14%31.35M | -32.21%108.2M | -17.96%116.08M | -20.87%85.75M | -12.24%45.53M | -8.70%159.6M | 10.76%141.48M | 38.99%108.36M |
| Total composite income of minority owners | 16.62%-9.44M | 27.12%-5.18M | 71.89%-854.67K | -66.63%-11.18M | -147.70%-11.32M | -265.97%-7.11M | -870.14%-3.04M | -109,585.79%-6.71M | -66,937.64%-4.57M | -33,186.06%-1.94M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm